Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710746 · ClinicalTrials.gov registry record · NA
Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program
A NA study of Overweight and Obesity, sponsored by Oregon Research Institute.
- Active
- Registry status
- NA
- Development phase
- 406
- Enrollment target
- 2
- Study locations
NCT03710746: Active NA study of Overweight and Obesity, sponsored by Oregon Research Institute.
NCT03710746 is a NA study of Overweight and Obesity that is active but no longer recruiting, run by Oregon Research Institute. The registered enrollment target is 406 participants, above the 225-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (80% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03710746, a NA study of Overweight and Obesity, is active but no longer recruiting, sponsored by Oregon Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 406 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project seeks to improve the effectiveness of a novel dissonance-based obesity prevention program that has reduced future BMI gain and overweight/obesity onset by (a) experimentally testing whether implementing it in single- versus mixed-sex groups, which should increase dissonance-induction that contributes to weight gain prevention effects, and (b) experimentally testing whether adding food response and attention training, which theoretically reduces valuation of and attention for high-calorie foods, increases weight gain prevention effects. This randomized trial would be the first to experimentally manipulate these two factors in an effort to produce superior weight gain prevention effects. A brief effective obesity prevention program that can be easily, inexpensively, and broadly implemented to late adolescents at risk for excess weight gain, as has been the case with another dissonance-based prevention program, could markedly reduce the prevalence of obesity and associated morbidity and mortality.
Conditions Studied
Interventions
- BEHAVIORAL Project Health
- BEHAVIORAL Response and Attention Training
Study Locations (2)
Oregon
- Oregon Research Institute - Eugene
Pennsylvania
- Drexel University - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 406 participants |
| Start Date | 2018-10-08 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the registry record for NCT03710746 still lists
NCT03710746 is an interventional study that assigns participants to a tested intervention. The registered 406 participants enrollment target is mid-sized for trials with a published cap, above the 225-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (80% higher).
The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Project Health is the first listed.
NCT03710746 reports a single indexed study location in Oregon, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03710746 about?
NCT03710746 is a clinical study titled "Project Health: Enhancing Effectiveness of a Dissonance-Based Obesity Prevention Program". This project seeks to improve the effectiveness of a novel dissonance-based obesity prevention program that has reduced future BMI gain and overweight/obesity onset by (a) experimentally testing whether implementing it in single- versus mixed-sex groups, which should increase dissonance-induction th...
What is the current status of trial NCT03710746?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 406 participants. The study started on 2018-10-08. Estimated completion is 2025-06-30.
What conditions does trial NCT03710746 study?
This clinical trial studies the following conditions: Overweight and Obesity.
What interventions are being tested in trial NCT03710746?
The interventions under investigation include: Project Health (BEHAVIORAL), Response and Attention Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT03710746?
This trial is sponsored by Oregon Research Institute, which has 62 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03710746 being conducted?
This trial has 2 study locations across Oregon, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Overweight and Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03710746's enrollment target sits among peer trials
406 17th of 115 higher than 99 of 115 other Overweight and Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dose Response Effects of Pecan Consumption
RECRUITING · NA
-
A Pilot Factorial Trial of an Integrated Lifestyle Intervention
RECRUITING · NA
-
Cottonseed Oil Dose Response
RECRUITING · NA
-
Cooking Skills to Improve Long-Term Weight Loss in Young Adults With Intellectual Disabilities
RECRUITING · NA
-
Testing the Adipose Expandability Hypothesis in Vivo During Overfeeding
RECRUITING · NA
-
Cottonseed Oil Versus Matched PUFA Effects
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06223360 · 406 participants · Phase 2
A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- NCT06411769 · 406 participants · NA
Evidence-based Intervention to Improve Walking Engagement in El Paso, Texas
- NCT06585787 · 406 participants · Phase 3
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- NCT06735534 · 407 participants · NA
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation System
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI